In addition to revealing prognostic value, this finding has significant implications for devising potential immunomodulatory therapy for patients with lung adenocarcinoma and squamous cell carcinoma; an intervention that decreases levels of FoxP3+ and increases levels of CD4+ or CD8+ TILs would likely to be beneficial. This evidence concerns the gene FOXP3 and lung adenocarcinoma.